Zoetis (ZTS) Other Accumulated Expenses (2013 - 2026)
Zoetis (ZTS) reported Other Accumulated Expenses of $751.0 million for Q1 2026, down 2.72% year-over-year from $772.0 million in Q1 2025, and up 588.99% quarter-over-quarter from $109.0 million in Q4 2025.
Zoetis (ZTS) Other Accumulated Expenses (2013 - 2026) Analysis & Trends
Zoetis (ZTS) has 14 years of Other Accumulated Expenses data on file, last reported at $751.0 million in Q1 2026.
- Other Accumulated Expenses for Q1 2026 came in at $751.0 million, down 2.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $751.0 million (down 2.72% YoY), and the FY2025 annual result was $109.0 million, down 12.8% from the prior year.
- Other Accumulated Expenses climbed to $751.0 million in Q1 2026 per ZTS's latest filing, from $109.0 million in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $809.0 million in Q3 2025 and troughed at $89.0 million in Q1 2024.
- A 5-year average of $369.2 million and a median of $125.0 million in 2024 frame the typical range for Other Accumulated Expenses.
- The sharpest annual moves came in 2024 and 2025: Other Accumulated Expenses sank 87.3% in 2024, then surged 767.42% in 2025.
- A 5-year view of Other Accumulated Expenses shows it stood at $97.0 million in 2022, then grew by 5.15% to $102.0 million in 2023, then advanced by 22.55% to $125.0 million in 2024, then fell by 12.8% to $109.0 million in 2025, then surged by 588.99% to $751.0 million in 2026.
- Business Quant data shows ZTS's Other Accumulated Expenses at $751.0 million in Q1 2026, $109.0 million in Q4 2025, and $809.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 751.00 Mn |
| Dec 31, 2025 | 109.00 Mn |
| Sep 30, 2025 | 809.00 Mn |
| Jun 30, 2025 | 770.00 Mn |
| Mar 31, 2025 | 772.00 Mn |
| Dec 31, 2024 | 125.00 Mn |
| Sep 30, 2024 | 725.00 Mn |
| Jun 30, 2024 | 93.00 Mn |
| Mar 31, 2024 | 89.00 Mn |
| Dec 31, 2023 | 102.00 Mn |
| Sep 30, 2023 | 97.00 Mn |
| Jun 30, 2023 | 107.00 Mn |
| Mar 31, 2023 | 701.00 Mn |
| Dec 31, 2022 | 97.00 Mn |
| Sep 30, 2022 | 134.00 Mn |
| Jun 30, 2022 | 696.00 Mn |
| Mar 31, 2022 | 99.00 Mn |
| Dec 31, 2021 | 67.00 Mn |
| Sep 30, 2021 | 618.00 Mn |
| Jun 30, 2021 | 646.00 Mn |